Скачать книгу

21 (8): 403–406.

      150 150 Estrela, C., Bammann, L.L., Estrela, C.R. et al. (2000). Antimicrobial and chemical study of MTA, Portland cement, calcium hydroxide paste, Sealapex and Dycal. Braz. Dent. J. 11 (1): 3–9.

      151 151 Al‐Hezaimi, K., Al‐Shalan, T.A., Naghshbandi, J. et al. (2006). Antibacterial effect of two mineral trioxide aggregate (MTA) preparations against Enterococcus faecalis and Streptococcus sanguis in vitro. J. Endod. 32 (11): 1053–1056.

      152 152 Stowe, T.J., Sedgley, C.M., Stowe, B., and Fenno, J.C. (2004). The effects of chlorhexidine gluconate (0.12%) on the antimicrobial properties of tooth‐colored ProRoot mineral trioxide aggregate. J. Endod. 30 (6): 429–431.

      153 153 Holt, D.M., Watts, J.D., Beeson, T.J. et al. (2007). The anti‐microbial effect against enterococcus faecalis and the compressive strength of two types of mineral trioxide aggregate mixed with sterile water or 2% chlorhexidine liquid. J. Endod. 33 (7): 844–847.

      154 154 Hernandez, E.P., Botero, T.M., Mantellini, M.G. et al. (2005). Effect of ProRoot MTA mixed with chlorhexidine on apoptosis and cell cycle of fibroblasts and macrophages in vitro. Int. Endod. J. 38 (2): 137–143.

      155 155 Rechenberg, D.K., De‐Deus, G., and Zehnder, M. (2011). Potential systematic error in laboratory experiments on microbial leakage through filled root canals: review of published articles. Int. Endod. J. 44 (3): 183–194.

      156 156 Wu, M.K. and Wesselink, P.R. (1993). Endodontic leakage studies reconsidered. Part I. Methodology, application and relevance. Int. Endod. J. 26 (1): 37–43.

      157 157 De‐Deus, G. (2008). New directions in old leakage methods. Int. Endod. J. 41 (8): 720–721; disc. 1–3.

      158 158 Torabinejad, M., Higa, R.K., McKendry, D.J., and Pitt Ford, T.R. (1994). Dye leakage of four root end filling materials: effects of blood contamination. J. Endod. 20 (4): 159–163.

      159 159 Martell, B. and Chandler, N.P. (2002). Electrical and dye leakage comparison of three root‐end restorative materials. Quintessence Int. 33 (1): 30–34.

      160 160 Wu, M.K., Kontakiotis, E.G., and Wesselink, P.R. (1998). Long‐term seal provided by some root‐end filling materials. J. Endod. 24 (8): 557–560.

      161 161 Karlovic, Z., Pezelj‐Ribaric, S., Miletic, I. et al. (2005). Erbium:YAG laser versus ultrasonic in preparation of root‐end cavities. J. Endod. 31 (11): 821–823.

      162 162 Fischer, E.J., Arens, D.E., and Miller, C.H. (1998). Bacterial leakage of mineral trioxide aggregate as compared with zinc‐free amalgam, intermediate restorative material, and Super‐EBA as a root‐end filling material. J. Endod. 24 (3): 176–179.

      163 163 Tang, H.M., Torabinejad, M., and Kettering, J.D. (2002). Leakage evaluation of root end filling materials using endotoxin. J. Endod. 28 (1): 5–7.

      164 164 Ford, T.R., Torabinejad, M., Abedi, H.R. et al. (1996). Using mineral trioxide aggregate as a pulp‐capping material. J. Am. Dent. Assoc. 127 (10): 1491–1494.

      165 165 Keiser, K., Johnson, C.C., and Tipton, D.A. (2000). Cytotoxicity of mineral trioxide aggregate using human periodontal ligament fibroblasts. J. Endod. 26 (5): 288–291.

      166 166 Faraco, I.M. Jr. and Holland, R. (2001). Response of the pulp of dogs to capping with mineral trioxide aggregate or a calcium hydroxide cement. Dent. Traumatol. 17 (4): 163–166.

      167 167 Asgary, S., Eghbal, M.J., Parirokh, M. et al. (2008). A comparative study of histologic response to different pulp capping materials and a novel endodontic cement. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 106 (4): 609–614.

      168 168 Kuratate, M., Yoshiba, K., Shigetani, Y. et al. (2008). Immunohistochemical analysis of nestin, osteopontin, and proliferating cells in the reparative process of exposed dental pulp capped with mineral trioxide aggregate. J. Endod. 34 (8): 970–974.

      169 169 Accorinte Mde, L., Holland, R., Reis, A. et al. (2008). Evaluation of mineral trioxide aggregate and calcium hydroxide cement as pulp‐capping agents in human teeth. J. Endod. 34 (1): 1–6.

      170 170 Min, K.S., Park, H.J., Lee, S.K. et al. (2008). Effect of mineral trioxide aggregate on dentin bridge formation and expression of dentin sialoprotein and heme oxygenase‐1 in human dental pulp. J. Endod. 34 (6): 666–670.

      171 171 Moghaddame‐Jafari, S., Mantellini, M.G., Botero, T.M. et al. (2005). Effect of ProRoot MTA on pulp cell apoptosis and proliferation in vitro. J. Endod. 31 (5): 387–391.

      172 172 Masuda‐Murakami, Y., Kobayashi, M., Wang, X. et al. (2010). Effects of mineral trioxide aggregate on the differentiation of rat dental pulp cells. Acta Histochem. 112 (5): 452–458.

      173 173 Simon, S., Cooper, P., Smith, A. et al. (2008). Evaluation of a new laboratory model for pulp healing: preliminary study. Int. Endod. J. 41 (9): 781–790.

      174 174 Laurent, P., Camps, J., and About, I. (2012). Biodentine(TM) induces TGF‐beta1 release from human pulp cells and early dental pulp mineralization. Int. Endod. J. 45 (5): 439–448.

      175 175 Sarkar, N.K., Caicedo, R., Ritwik, P. et al. (2005). Physicochemical basis of the biologic properties of mineral trioxide aggregate. J. Endod. 31 (2): 97–100.

      176 176 Reyes‐Carmona, J.F., Felippe, M.S., and Felippe, W.T. (2009). Biomineralization ability and interaction of mineral trioxide aggregate and white Portland cement with dentin in a phosphate‐containing fluid. J. Endod. 35 (5): 731–736.

      177 177 Tomson, P.L., Lumley, P.J., Alexander, M.Y. et al. (2013). Hepatocyte growth factor is sequestered in dentine matrix and promotes regeneration‐associated events in dental pulp cells. Cytokine 61 (2): 622–629.

      178 178 Tomson, P.L., Lumley, P.J., Smith, A.J., and Cooper, P.R. (2016). Growth factor release from dentine matrix by pulp capping agents promote pulp tissue repair‐associated events. Int. Endod. J. 50 (3): 281–292.

      179 179 Gandolfi, M.G., Siboni, F., and Prati, C. (2012). Chemical‐physical properties of TheraCal, a novel light‐curable MTA‐like material for pulp capping. Int. Endod. J. 45 (6): 571–579.

      180 180 Camilleri, J., Laurent, P., and About, I. (2014). Hydration of Biodentine, Theracal LC, and a prototype tricalcium silicate‐based dentin replacement material after pulp capping in entire tooth cultures. J. Endod. 40 (11): 1846–1854.

      181 181 Nilsen, B.W., Jensen, E., Ortengren, U., and Michelsen, V.B. (2017). Analysis of organic components in resin‐modified pulp capping materials: critical considerations. Eur. J. Oral Sci. 125 (3): 183–194.

      182 182 Gomes‐Filho, J.E., de Faria, M.D., Bernabe, P.F. et al. (2008). Mineral trioxide aggregate but not light‐cure mineral trioxide aggregate stimulated mineralization. J. Endod. 34 (1): 62–65.

      183 183 Koutroulis, A., Kuehne, S.A., Cooper, P.R., and Camilleri, J. (2019). The role of calcium ion release on biocompatibility and antimicrobial properties of hydraulic cements. Sci. Rep. 9 (1): 19019.

      184 184 Gandolfi, M.G., Siboni, F., Botero, T. et al. (2015). Calcium silicate and calcium hydroxide materials for pulp capping: biointeractivity, porosity, solubility and bioactivity of current formulations. J. Appl. Biomater. Funct. Mater. 13 (1): 43–60.

      185 185 Yamamoto, S., Han, L., Noiri, Y., and Okiji, T. (2017). Evaluation of the Ca ion release, pH and surface apatite formation of a prototype tricalcium silicate cement. Int. Endod. J. 50 (Suppl. 2): e73–e82.

      186 186 Hebling, J., Lessa, F.C., Nogueira, I. et al. (2009). Cytotoxicity of resin‐based light‐cured liners. Am. J. Dent. 22 (3): 137–142.

      187 187 Jeanneau, C., Laurent, P., Rombouts, C. et al. (2017). Light‐cured tricalcium silicate toxicity to the dental pulp. J. Endod. 43 (12): 2074–2080.

      188 188 Lee, H., Shin, Y., Kim, S.O. et al. (2015). Comparative study of pulpal responses to pulpotomy with ProRoot MTA, RetroMTA, and TheraCal in dogs' teeth. J. Endod. 41 (8): 1317–1324.

      189 189 Bakhtiar, H., Nekoofar, M.H., Aminishakib, P. et al. (2017). Human pulp responses to partial pulpotomy treatment with TheraCal as compared with biodentine and ProRoot MTA: a clinical